Data / Form D filings / Rocket Pharmaceuticals Ltd.
Rocket Pharmaceuticals Ltd.: Form D filings
Rocket Pharmaceuticals Ltd., a biotechnology company in Grand Cayman, Cayman Islands, filed 3 Form D notices with the SEC between 2016 and 2017. The latest, on May 5, 2017, reports $25.1 million sold of a $30.1 million offering to 15 investors.
Find out what Rocket Pharmaceuticals Ltd. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- CO Services Cayman Limited, PO Box 10008, WILLOW HOUSE, CRICKET SQUARE, Grand Cayman, Cayman Islands, KY1-1
- Phone
- (345) 749-2000
- Industry
- Biotechnology
- Entity type
- Other (Cayman Islands exempted company)
- Incorporated in
- Cayman Islands
- Year incorporated
- 2015
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1663128
The full lists. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 5, 2017 | Amendment | $30,075,000 | $25,137,888 | $4,937,112 | 15 | Feb 14, 2017 | sec.gov |
| Mar 2, 2017 | New notice | $30,075,000 | $12,024,787 | $18,050,213 | 11 | Feb 14, 2017 | sec.gov |
| Jan 15, 2016 | New notice | $37,963,000 | $16,425,000 | $21,538,000 | 16 | Dec 21, 2015 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Naveen Yalamanchi | Director | |
| Gaurav Shah | Executive Officer | |
| Roderick Wong | Director |
Every Form D from the week of May 1, 2017 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Rocket Pharmaceuticals Ltd. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.